LS Investment Advisors LLC reduced its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 2.7% during the 4th quarter, Holdings Channel reports. The firm owned 30,842 shares of the healthcare conglomerate’s stock after selling 844 shares during the quarter. LS Investment Advisors LLC’s holdings in UnitedHealth Group were worth $6,799,000 at the end of the most recent quarter.
Several other large investors have also recently added to or reduced their stakes in the company. Exane Derivatives boosted its holdings in UnitedHealth Group by 15,333.3% in the fourth quarter. Exane Derivatives now owns 463 shares of the healthcare conglomerate’s stock valued at $102,000 after acquiring an additional 460 shares during the last quarter. Acrospire Investment Management LLC boosted its holdings in UnitedHealth Group by 130.7% in the second quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock valued at $131,000 after acquiring an additional 400 shares during the last quarter. Intellectus Partners LLC boosted its holdings in UnitedHealth Group by 18.2% in the second quarter. Intellectus Partners LLC now owns 818 shares of the healthcare conglomerate’s stock valued at $152,000 after acquiring an additional 126 shares during the last quarter. Wealthcare Advisory Partners LLC boosted its holdings in UnitedHealth Group by 461.9% in the third quarter. Wealthcare Advisory Partners LLC now owns 826 shares of the healthcare conglomerate’s stock valued at $162,000 after acquiring an additional 679 shares during the last quarter. Finally, Legacy Advisors LLC boosted its holdings in UnitedHealth Group by 546.0% in the fourth quarter. Legacy Advisors LLC now owns 801 shares of the healthcare conglomerate’s stock valued at $176,000 after acquiring an additional 677 shares during the last quarter. Institutional investors own 86.78% of the company’s stock.
Several analysts recently commented on the company. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $254.00 target price on the stock in a report on Wednesday. Cantor Fitzgerald reissued a “buy” rating and issued a $280.00 price target on shares of UnitedHealth Group in a research note on Thursday, March 8th. Barclays began coverage on UnitedHealth Group in a research note on Thursday, March 8th. They issued an “overweight” rating and a $265.00 price target on the stock. Citigroup boosted their price target on UnitedHealth Group from $235.00 to $268.00 and gave the company a “buy” rating in a research note on Wednesday, January 17th. Finally, Oppenheimer boosted their price target on UnitedHealth Group from $215.00 to $225.00 and gave the company an “outperform” rating in a research note on Wednesday, November 29th. Two equities research analysts have rated the stock with a hold rating and twenty-six have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $244.62.
UnitedHealth Group stock opened at $212.55 on Friday. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.58. UnitedHealth Group Inc has a 12-month low of $162.74 and a 12-month high of $250.79. The firm has a market capitalization of $208,250.73, a P/E ratio of 19.85, a PEG ratio of 1.25 and a beta of 0.74.
UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, topping analysts’ consensus estimates of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The company had revenue of $52.06 billion for the quarter, compared to analyst estimates of $51.57 billion. During the same period in the prior year, the firm earned $2.11 earnings per share. UnitedHealth Group’s revenue for the quarter was up 9.5% on a year-over-year basis. research analysts predict that UnitedHealth Group Inc will post 12.52 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Tuesday, March 20th. Stockholders of record on Friday, March 9th were given a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.41%. The ex-dividend date was Thursday, March 8th. UnitedHealth Group’s payout ratio is 28.01%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.